Your search returned 5 results.

Results
	1.	Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs. [electronic resource] by Fadoukhair, Z Zardavas, D Chad, M A Goulioti, T Aftimos, P Piccart, M Producer: 20160826 In: Oncogene vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis. [electronic resource] by Bareche, Y Venet, D Ignatiadis, M Aftimos, P Piccart, M Rothe, F Sotiriou, C Producer: 20191125 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer. [electronic resource] by Ghosn, M Aftimos, P Farhat, F S Kattan, J G Hanna, C Haddad, N Nasr, F Chahine, G Producer: 20120822 In: Medical oncology (Northwood, London, England) vol. 28 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The AURORA initiative for metastatic breast cancer. [electronic resource] by Zardavas, D Maetens, M Irrthum, A Goulioti, T Engelen, K Fumagalli, D Salgado, R Aftimos, P Saini, K S Sotiriou, C Campbell, P Dinh, P von Minckwitz, G Gelber, R D Dowsett, M Di Leo, A Cameron, D Baselga, J Gnant, M Goldhirsch, A Norton, L Piccart, M Producer: 20150120 In: British journal of cancer vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. [electronic resource] by Gebhart, G Lamberts, L E Wimana, Z Garcia, C Emonts, P Ameye, L Stroobants, S Huizing, M Aftimos, P Tol, J Oyen, W J G Vugts, D J Hoekstra, O S Schröder, C P Menke-van der Houven van Oordt, C W Guiot, T Brouwers, A H Awada, A de Vries, E G E Flamen, P Producer: 20161213 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)